Improving a Natural CaMKII Inhibitor by Random and Rational Design
Author Information
Author(s): Coultrap Steven J., Bayer K. Ulrich
Primary Institution: Department of Pharmacology, University of Colorado Denver - School of Medicine, Aurora, Colorado, United States of America
Hypothesis
The goal of this study was to identify the residues required for CaMKII inhibition, and to assess if artificial mutations could further improve the potency achieved during evolution.
Conclusion
The study provides improved research tools for studying CaMKII function and indicates that evolution fine-tuned CaM-KIIN not for maximal potency of CaMKII inhibition, but for lower potency that may be optimal for dynamic regulation of signal transduction.
Supporting Evidence
- CN19 was identified as the minimal region that contains the full inhibitory potency.
- Mutational analysis showed that the region around R11 of CN19 is of special importance.
- The optimized peptide CN19o was found to have an IC50 of <0.4 nM, indicating significantly improved potency.
Takeaway
Scientists wanted to make a better tool to study a brain protein called CaMKII, and they found ways to make it work much better than before.
Methodology
The study involved identifying the minimal inhibitory region of CaM-KIIN and performing mutational analysis to assess the effects on CaMKII inhibition.
Statistical Information
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website